- Daily Industry Report
- Posts
- Daily Industry Report - April 29
Daily Industry Report - April 29
Your summary of the Voluntary and Healthcare Industry’s most relevant and breaking news; brought to you by the Health & Voluntary Benefits Association®
Jake Velie, CPT | Robert S. Shestack, CCSS, CVBS, CFF |
Hospital M&A studies highlight higher prices, tepid antitrust intervention
By Dave Muio - A pair of academic studies published this week painted an unflattering picture of hospital dealmaking's impact on healthcare prices and regulators' track record of stepping in to protect market competition. Read Full Article…
VBA Article Summary
Cross-market Hospital Mergers Drive Price Increases: Research published in Health Services Research highlights the impact of cross-market hospital mergers, revealing a significant 13% average price increase compared to control hospitals six years post-merger. Despite no challenges from the Federal Trade Commission (FTC), these mergers are associated with higher prices, signaling potential antitrust concerns.
Underenforcement of Antitrust Laws in Hospital Sector: A study in American Economic Review: Insights sheds light on the underenforcement of antitrust laws within the hospital industry. Despite a fifth of hospital merger deals meeting the FTC's market concentration threshold, only 1% faced challenges. The study suggests that a lack of funding for antitrust enforcement agencies contributes to this underenforcement, with mergers leading to notable healthcare price increases.
FTC's Limited Response Sparks Debate: Amid concerns over underenforcement, the FTC's response to hospital mergers faces scrutiny. While research indicates that FTC scrutiny could prevent price increases, the agency has historically challenged only a fraction of potentially problematic mergers. The debate highlights the need for more robust antitrust enforcement to maintain competition and control healthcare costs.
How The FTC’s Ban On Noncompetes Will Transform The Tech Industry
By Soulaima Gourani - The U.S. Federal Trade Commission's recent decision to invalidate most noncompete agreements is a pivotal moment that demands attention from leaders in all sectors. Read Full Article…
VBA Article Summary
FTC's Rule: A Paradigm Shift in Employment Agreements: The FTC's new rule, set to take effect in four months, challenges the longstanding practice of noncompete agreements, impacting approximately 30 million workers. This move reflects a growing consensus that such agreements stifle innovation and unfairly limit workers' career advancements, particularly in tech and other industries.
Global Ramifications: Redefining Tech Industry Dynamics: While the FTC's rule applies within the U.S., its implications are far-reaching, potentially reshaping global tech ecosystems. The interconnected nature of the tech industry, coupled with the precedent set by Silicon Valley and California's unenforceable noncompete laws, may prompt other countries to reevaluate their own policies. This shift could foster a more interconnected and innovative global tech landscape, benefiting businesses and consumers worldwide.
Economic and Industry Transformation: The removal of noncompetes is projected to catalyze entrepreneurship, innovation, and economic growth. Estimates suggest an annual creation of 8,500 new businesses and an increase of up to 29,000 patents per year over the next decade. Additionally, workers stand to benefit from an average annual pay increase of $524, gaining newfound freedom to explore opportunities and contribute to a more dynamic and competitive tech sector.
FDA Launches ‘Home as a Health Care Hub’ Initiative With Equity Focus
By David Raths - The U.S. Food and Drug Administration has launched an initiative, Home as a Health Care Hub, to help reimagine the home environment as an integral part of the healthcare system. Read Full Article…
VBA Article Summary
Holistic Home Healthcare Integration: The FDA highlights the deficiency in current home healthcare solutions, noting their lack of consideration for the structural and critical elements of the home environment. Existing devices often operate in isolation, requiring patients to manage disparate medical tools. To address this, the FDA is spearheading a partnership to design an Augmented Reality/Virtual Reality-enabled prototype home, fostering seamless integration of medical-grade, consumer-designed technologies into daily life.
Equity-Focused Innovation: Collaborating with an architectural firm and stakeholders like patient groups and healthcare providers, the FDA aims to create a "Home as a Health Care Hub." This initiative seeks to tackle health inequity by prioritizing underserved populations and rural communities. By starting with rural and lower-income dwellings, the prototype will serve as a catalyst for advancing health equity, ensuring that home-based healthcare solutions are accessible and tailored to diverse needs.
Addressing Diabetes as a Test Case: Recognizing the substantial economic burden and disproportionate impact of diabetes on underserved communities, the FDA is focusing on this condition as an example for the hub prototype. With over $300 billion spent annually on diabetes-related medical costs in the U.S., there's a pressing need for innovative solutions that alleviate this burden. By leveraging the hub prototype, stakeholders can explore novel approaches to diabetes management that enhance patient outcomes and reduce healthcare disparities.
Joint Commission launches new telehealth stamp of approval for virtual healthcare providers
By Emma Beavis - The Joint Commission announced Tuesday a new set of accreditation standards for telehealth and remote patient monitoring companies. Virtual-only companies can receive the third-party healthcare accrediting organization’s trademarked gold seal of approval beginning July 2024. Read Full Article…
VBA Article Summary
Expansion of Accreditation Scope: The Joint Commission introduces new standards to replace existing technology and telehealth accreditation products in its ambulatory and behavioral health accreditation programs. These updated standards enable healthcare organizations to apply for accreditation if they offer virtual-only telehealth or remote monitoring services, expanding the scope of eligible providers.
Inclusive Coverage: The revised standards accommodate healthcare organizations providing telehealth services to other organizations’ patients, such as psychiatric hospitals offering tele-psychiatry through contracts. This inclusive approach acknowledges the growing interconnectivity of healthcare services and ensures that providers delivering telehealth services meet accreditation requirements.
Telehealth-Specific Standards: Developed in collaboration with technical advisory panels and external experts, the new standards reflect the evolving landscape of telehealth. They include provisions for remote emergency management, education for providers and patients on telehealth platforms and devices, and guidelines for telehealth equipment, devices, and connectivity. These telehealth-specific standards aim to uphold patient safety and quality of care, aligning with The Joint Commission's mission to standardize care delivery across diverse settings.
HVBA Poll Question - Please share your insightsWhen it comes to receiving compensation on insurance programs, which payment structure do you prefer? |
Our last poll results are in!
53.96%
of Daily Industry Report readers who responded to our last polling question “strongly disagree” with “RWJBarnabas’ decision to drop coverage of medications for weight loss among employees, as reported in the article referenced below*.”
14.06% of respondents “disagree,” 11.68% “strongly agree,” 10.19% “agree” while 10.11% are “neutral.”
*Article Reference: States clamping down on coverage of weight-loss drugs
Have a poll question you’d like to suggest? Let us know!
Kaiser Permanente: Data Breach Might Affect 13.4M Members
By Mark Hagland - The Oakland, Calif.-based Kaiser Permanente organization has experienced a data breach that involves the data of 13.4 million members; the health plan has filed a legally required notice with the Department of Health and Human Services (HHS) of the breach, which is the largest confirmed healthcare-related data breach of 2024 so far. Read Full Article…
VBA Article Summary
Data Breach Scope and Response: Kaiser, a prominent U.S. health conglomerate, recently faced a significant data breach affecting millions of current and former members. The breach involved the unauthorized sharing of patient information with third-party advertisers, including tech giants like Google, Microsoft, and X (formerly Twitter). Kaiser conducted an investigation and confirmed that certain online technologies installed on its websites and mobile applications had transmitted personal information to these vendors. The compromised data included member names, IP addresses, sign-in statuses, website interactions, and search terms used on health-related platforms. In response, Kaiser promptly removed the tracking code from its digital platforms and initiated notification procedures.
Extent of Impact and Regulatory Response: The breach potentially affects 13.4 million individuals who accessed Kaiser's websites and mobile applications, representing both current and former members. Kaiser's proactive approach includes notifying affected parties "out of an abundance of caution." While it remains unclear how many individuals had their personal information transmitted to the tech companies, this incident marks the largest health-related breach of the year, as reported by the HHS' breach portal. Despite the absence of highly sensitive information like passwords or financial details, the breach raises concerns about the exposure of personal browsing habits and navigation patterns on healthcare platforms. Kaiser has filed notices with the U.S. government and California's attorney general to address the breach and comply with regulatory obligations.
Healthcare Cybersecurity Landscape: The breach underscores the persistent cybersecurity challenges faced by healthcare organizations, which remain prime targets for cybercriminals due to the sensitive nature of the data they handle. This incident adds to a series of recent cybersecurity breaches within the healthcare sector, including ransomware attacks and supply chain compromises. Notable examples include the ransomware attack on Change Healthcare, which resulted in the theft of valuable files, and the supply chain attack on ESO Solutions, affecting multiple healthcare organizations. These incidents highlight the urgent need for robust cybersecurity measures and proactive risk management strategies within the healthcare industry to safeguard patient data and mitigate the growing threat of cyberattacks.
Experts Aren’t Surprised About Optum Closing Its Virtual Care Business
By Katie Adams - Optum is shutting down its virtual care business after a three-year run. Industry experts aren’t very surprised by the news. Healthcare leaders agree that this closure reflects broader trends in the telehealth market, in which saturation and differentiation challenges are leading some providers to struggle. Read Full Article…
VBA Article Summary
Optum's Closure Highlights Shift Towards Personalized and Niche Virtual Care: Optum's decision to shut down its virtual care unit underscores a broader trend in the healthcare industry towards personalized patient experiences and niche community needs. As telehealth hype wanes post-pandemic, companies like Optum are recognizing the importance of tailoring care to specific patient demographics and health conditions.
Rise of Hybrid Care Models Signals Industry Evolution: The closure of Optum's virtual care business reflects a growing acknowledgment of the limitations of virtual-only care models. Experts emphasize the emergence of hybrid care approaches that seamlessly integrate virtual and in-person visits. This shift suggests a strategic move by healthcare companies to meet evolving patient preferences and improve overall care quality.
Success Lies in Patient-Centric Approach and Community Focus: Amidst increasing competition and market saturation, successful virtual care providers will prioritize the patient experience and community-specific needs. Companies like Tia, Found, and Folx Health exemplify this trend by offering tailored care solutions for women, personalized weight loss programs, and specialized services for the LGBTQ+ community, respectively. By focusing on niche patient populations and delivering personalized care, virtual care providers can differentiate themselves and thrive in a changing healthcare landscape.
Walgreens expands specialty pharmacy business to gene and cell therapy services
By Heather Landi - Walgreens is expanding its specialty pharmacy services to offer gene and cell therapy services, supported by a dedicated 18,000-square-foot center in Pittsburgh, the company announced Thursday. Read Full Article…
VBA Article Summary
Integration for Enhanced Specialty Pharmacy Services: Walgreens' newly integrated business unit, Walgreens Specialty Pharmacy, consolidates its specialty pharmacy segment assets, including AllianceRx. This integration streamlines operations under the Walgreens U.S. retail pharmacy segment, fostering a more cohesive approach to specialty pharmacy services.
Independent Specialty Pharmacy Offering: Walgreens' integrated model allows it to collaborate directly with payers, health plans, and pharmaceutical companies for specialty pharmacy services, bypassing traditional pharmacy benefit managers (PBMs). This independent approach aims to enhance flexibility and optimize patient care pathways.
Expansion into Gene Therapy and Comprehensive Care: In response to the growing demand for specialized healthcare, Walgreens unveils its gene and cell services pharmacy and innovation center in Pittsburgh. This initiative demonstrates the company's commitment to providing solutions for emerging therapies, such as gene therapies for rare hereditary diseases. Moreover, with a focus on comprehensive care, Walgreens' specialty pharmacy services aim to mitigate costs and improve patient outcomes through an integrated care model spanning pharmacy teams, distribution networks, providers, and payers.
There's a big market for healthcare data analytics. Here's how Trilliant Health is making moves to stand out
By Heather Landi - The $4 trillion healthcare industry is a data-rich sector, and every healthcare player is trying to find a way to use information to drive better decisions, whether in the clinic or the boardroom. Read Full Article…
VBA Article Summary
Rising Complexity and Competition in Healthcare: With regulatory ambiguity, diminishing reimbursement rates, and intensified competition from retail giants like Walgreens and Amazon, the healthcare sector faces unprecedented challenges. This convergence underscores the urgency for data-driven decision-making to navigate the evolving landscape effectively.
Trilliant Health's Vision for Strategic Analytics: Trilliant Health, formed from the merger of three companies, aims to democratize strategic analytics in healthcare. By leveraging comprehensive data sets and advanced analytics, the company seeks to empower stakeholders across the healthcare ecosystem with evidence-based insights, akin to strategies used in other industries.
Localized Data Insights Driving Growth Strategies: Trilliant Health's approach prioritizes localized data analytics, offering granular insights into market dynamics and consumer behavior. This shift enables healthcare organizations to tailor growth strategies based on precise demand forecasts and market share assessments, fostering consumer-centric approaches amidst increasing competition and consumer demands for convenience.
Exclusive: In $1B+ bet on AI, biopharma heavyweights back new startup to upend drug R&D
By Andrew Dunn and Ryan Cross - A star-studded mix of venture capitalists and scientists, backed by more than a billion dollars, is launching an ambitious biotech that aims to reinvent drug R&D using artificial intelligence, the group exclusively told Endpoints News. Read Full Article…
VBA Article Summary
Leadership and Vision: Xaira Therapeutics, led by former Stanford University president Marc Tessier-Lavigne, boasts a robust executive team and board comprising industry luminaries like Scott Gottlieb and Alex Gorsky. The company aims to harness AI to overhaul drug discovery, emphasizing the potential for significant improvements in speed and success rates.
Cutting-Edge Technology: Leveraging AI methods developed at the University of Washington's Institute for Protein Design, Xaira is pioneering generative AI techniques to design complex molecules, identify new targets, and streamline the drug development process. With a focus on antibody generation and molecular design, Xaira aims to revolutionize drug discovery by combining computational power with biological insight.
Strategic Focus and Expansion: Xaira's initial focus lies in three key areas: discovering new biology, designing molecules, and optimizing clinical trials. By integrating technologies from partners like Illumina and Interline Therapeutics, the company aims to expand its AI-driven approach beyond antibody drugs to potentially include small molecules, with the ultimate goal of delivering precision medicines tailored to individual patients.
Employer-Provided Health Plans Generate Major ROI for Companies, Employees
By AHIP - More than half of all Americans – over 180 million hardworking individuals and their families – receive their health coverage through their jobs. Employer-provided coverage delivers affordable access to care, effective ways to improve health, and peace-of-mind. Read Full Article…
VBA Article Summary
Increasing ROI in Health Coverage: Avalere Health's study highlights a significant 47% return on investment (ROI) for employers with 100 or more workers offering health coverage in 2022. This ROI is projected to rise to 52% by 2026, indicating a substantial financial benefit for businesses. The ROI encompasses enhanced recruitment and retention, improved productivity, reduced medical costs and disability claims, and tax advantages.
Financial Benefits for Employers: By 2026, employers are expected to reap $346.6 billion in returns, comprising $108 billion in direct medical cost reductions and $139.70 billion in tax benefits, as per Avalere's estimates. This financial gain underscores the importance of investing in quality, affordable health benefits for employees, not just as a moral obligation but as a strategic business move.
Strategic Investment in Workforce Well-being: Offering health coverage isn't merely about meeting a basic need; it's a strategic move that positions companies as competitive players in the job market. As highlighted by industry experts like Ray McCarty, president of Associated Industries of Missouri, and small business owner Dwayne K., investing in employee health fosters loyalty, attracts top talent, and ultimately leads to a healthier, more productive workforce. The Avalere study reaffirms that employer-provided coverage not only enhances employee well-being but also strengthens the workforce, providing tangible benefits for both employers and employees alike.
The Fascinating Way to Measure Glucose With a Phone's Compass
By Christina Szalinski - Here's a new direction for smartphones in healthcare. Researchers from the National Institute of Standards and Technology (NIST), Boulder, Colorado, say a smartphone compass could be used to analyze biomarkers in body fluids — blood, sweat, urine, or saliva — to monitor or diagnose disease. Read Full Article…
VBA Article Summary
Innovative Sensing Technique: Researchers have developed a novel method for sensing glucose and pH levels using a smartphone's magnetometer and a strip of "smart hydrogel." This approach, spearheaded by Gary Zabow, PhD, from NIST, demonstrates a promising avenue for accessible and portable sensing technology, with potential applications in both medical and environmental monitoring.
Proof-of-Concept Study: In a proof-of-concept study, the researchers successfully measured glucose levels in beverages like sangria, pinot grigio, and champagne, as well as pH levels in coffee, orange juice, and root beer. The detection limit achieved micromolar concentrations, comparable to or better than existing glucose sensors, showcasing its viability for practical use.
Challenges and Future Directions: While the technology holds exciting prospects, further testing is required to validate its efficacy in biological fluids before it can be widely implemented in clinical or commercial settings. Challenges such as potential interference from other molecules in complex fluids like blood need to be addressed. Nonetheless, the potential for detecting various biomarkers beyond glucose, along with applications in water quality testing, suggests a promising future for this innovative sensing approach.